Financial statements Wiesiołek -Pharma

Balance sheet of Wiesiołek -Pharma

Company age:
Age:
4 y. 11 m. 20 d.
Share capital:
Share capital:
5 000 PLN

Balance sheet data of WIESIOŁEK -PHARMA

Year
2020
2022
2023
Total assets 7 832,65 215 314,99 2 024 266,66
A. Fixed assets 5 429,00 72 000,00 68 550,00
B. Current assets 2 403,65 143 314,99 1 955 716,66
C. Share capital contributions (basic funds) 0,00 0,00 0,00
D. Own shares (stocks) 0,00 0,00 0,00
Total liabilities 7 832,65 215 314,99 2 024 266,66
A. Equity -11 662,71 -9 657,83 290 959,08
B. Liabilities and provisions for liabilities 19 495,36 224 972,82 1 733 307,58
I. Long-term liabilities 0,00 0,00 0,00
II. Short-term liabilities 19 495,36 224 972,82 1 733 307,58
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.

  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.